A recent study published in PubMed examines the skeletal effects of a 5-year high-dose cyclical etidronate treatment in patients with pseudoxanthoma elasticum. The findings contribute to understanding potential therapeutic approaches for this rare condition.
skeletal effects of 5 year high dose cyclical etidronate in patients with pseudoxanthoma elasticum
Original title: “Skeletal effects of 5-year high-dose cyclical etidronate in patients with pseudoxanthoma elasticum.”